Is a low Total Cholesterol to HDL ratio good?

A low total cholesterol to HDL ratio is excellent for heart health, with optimal levels below 3.5:1. Lower ratios indicate more protective HDL cholesterol relative to total cholesterol, reducing cardiovascular disease risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Total Cholesterol to HDL Ratio

The total cholesterol to HDL ratio is a powerful predictor of cardiovascular health that provides more insight than looking at cholesterol numbers in isolation. This ratio compares your total cholesterol level to your high-density lipoprotein (HDL) cholesterol, often called "good" cholesterol. By examining this relationship, healthcare providers can better assess your risk for heart disease and stroke.

To calculate your ratio, simply divide your total cholesterol by your HDL cholesterol. For example, if your total cholesterol is 200 mg/dL and your HDL is 50 mg/dL, your ratio would be 4:1. This single number can reveal whether you have enough protective HDL cholesterol relative to your total cholesterol burden.

Understanding your cholesterol ratio is crucial for cardiovascular health optimization. Regular monitoring through comprehensive testing can help you track improvements and make informed decisions about your heart health.

Total Cholesterol to HDL Ratio Risk Categories

Risk categories based on American Heart Association guidelines. Individual risk may vary based on other factors.
Ratio RangeRisk CategoryCardiovascular RiskRecommended Action
Below 3.5:1Below 3.5:1OptimalLow riskMaintain healthy habits
3.5-4.0:13.5-4.0:1DesirableModerate riskMinor lifestyle adjustments
4.1-5.0:14.1-5.0:1Borderline HighIncreased riskActive lifestyle intervention
Above 5.0:1Above 5.0:1High RiskSignificantly elevatedMedical consultation recommended

Risk categories based on American Heart Association guidelines. Individual risk may vary based on other factors.

Why a Low Ratio Is Beneficial

A low total cholesterol to HDL ratio is indeed good for your health. Research consistently shows that people with lower ratios have significantly reduced risk of cardiovascular disease, heart attacks, and strokes. This protective effect occurs because a lower ratio indicates you have proportionally more HDL cholesterol, which actively removes excess cholesterol from your arteries and transports it to your liver for disposal.

HDL cholesterol acts like a cleanup crew in your bloodstream, performing what's called reverse cholesterol transport. It scavenges excess cholesterol from artery walls and other tissues, preventing the formation of dangerous plaques that can lead to atherosclerosis. When your ratio is low, it means this protective mechanism is working efficiently relative to your total cholesterol load.

Studies have shown that for every 1-point decrease in the total cholesterol to HDL ratio, cardiovascular risk drops by approximately 15-20%. This makes the ratio one of the most powerful modifiable risk factors for heart disease, more predictive than total cholesterol or LDL cholesterol alone.

Optimal Ratio Ranges and Risk Categories

Understanding where your ratio falls on the risk spectrum helps you set appropriate health goals. Medical guidelines have established clear categories based on extensive research linking ratios to cardiovascular outcomes.

Gender Differences in Optimal Ratios

Women typically have higher HDL cholesterol levels than men, resulting in naturally lower ratios. Premenopausal women often have ratios below 3.5:1, while men of the same age might have ratios closer to 4.5:1. After menopause, women's HDL levels often decline, making ratio management increasingly important for cardiovascular protection.

Your ideal ratio may vary slightly with age. While younger adults should aim for ratios below 3.5:1, some flexibility exists for older adults where ratios up to 4:1 may still be considered acceptable, particularly if other cardiovascular risk factors are well-controlled. However, maintaining a lower ratio remains beneficial regardless of age.

Factors That Influence Your Ratio

Multiple factors affect your total cholesterol to HDL ratio, many of which are within your control. Understanding these influences empowers you to make targeted lifestyle changes that can dramatically improve your cardiovascular health profile.

Dietary Impact

Your diet plays a crucial role in determining your cholesterol ratio. Saturated and trans fats tend to raise total cholesterol more than HDL, worsening your ratio. Conversely, monounsaturated fats from sources like olive oil, avocados, and nuts can improve your ratio by raising HDL while maintaining or lowering total cholesterol. Omega-3 fatty acids from fatty fish also enhance HDL function and can modestly increase HDL levels.

Physical Activity and Exercise

Regular aerobic exercise is one of the most effective ways to improve your cholesterol ratio. Studies show that 150 minutes of moderate-intensity exercise weekly can increase HDL by 5-10% while reducing total cholesterol. High-intensity interval training (HIIT) may be particularly effective, with some research showing HDL increases of up to 15% with consistent training.

Lifestyle and Medical Factors

  • Smoking: Lowers HDL by up to 15% and increases total cholesterol
  • Alcohol: Moderate consumption may raise HDL, but excessive drinking harms overall health
  • Weight: Every 10 pounds of weight loss can increase HDL by 1-2 mg/dL
  • Sleep: Poor sleep quality is associated with lower HDL and higher total cholesterol
  • Stress: Chronic stress elevates cortisol, which can worsen your ratio
  • Medications: Statins, niacin, and fibrates can improve ratios differently

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

How to Improve Your Cholesterol Ratio

Improving your total cholesterol to HDL ratio requires a two-pronged approach: raising HDL cholesterol while managing total cholesterol levels. The most effective strategies combine dietary modifications, increased physical activity, and lifestyle optimization.

Dietary changes should focus on replacing saturated fats with heart-healthy alternatives. Include fatty fish twice weekly, use olive oil as your primary cooking fat, and consume a handful of nuts daily. Increase soluble fiber intake through oats, beans, and vegetables, which can lower total cholesterol by 5-10%. Limit refined carbohydrates and added sugars, as these can suppress HDL production.

For exercise, combine aerobic activities with resistance training. Aim for at least 30 minutes of brisk walking, cycling, or swimming most days. Add strength training twice weekly, as building muscle mass improves overall metabolic health and can enhance HDL function. Even small increases in daily movement, like taking stairs or parking farther away, contribute to ratio improvement.

If lifestyle modifications alone don't achieve your target ratio, medications may help. Statins primarily lower LDL and total cholesterol, indirectly improving your ratio. Niacin can raise HDL by 15-35%, though it's less commonly prescribed due to side effects. Fibrates moderately increase HDL while lowering triglycerides. Work with your healthcare provider to determine if medication is appropriate for your situation.

Monitoring Your Progress

Regular monitoring is essential for tracking improvements in your cholesterol ratio and adjusting your approach as needed. Most experts recommend testing every 3-6 months when actively working to improve your levels, then annually once you've achieved your goals. Comprehensive lipid panels that include advanced markers like ApoB and ApoA can provide deeper insights into your cardiovascular risk profile.

When tracking your progress, remember that HDL changes occur more slowly than total cholesterol changes. It may take 2-3 months of consistent lifestyle modifications to see significant HDL improvements. Keep a log of your ratios over time, noting any lifestyle changes, to identify what works best for your body.

Beyond the Basic Ratio: Advanced Cardiovascular Markers

While the total cholesterol to HDL ratio provides valuable information, advanced lipid testing can offer even more precise cardiovascular risk assessment. Apolipoprotein B (ApoB) measures the number of atherogenic particles in your blood, while Apolipoprotein A1 (ApoA1) reflects HDL particle count. The ApoB to ApoA1 ratio may be even more predictive of cardiovascular risk than traditional cholesterol ratios.

Other important markers include lipoprotein(a), which is genetically determined and indicates inherited cardiovascular risk, and inflammatory markers like high-sensitivity C-reactive protein (hs-CRP). These advanced tests can help identify hidden risks even when traditional cholesterol ratios appear optimal, allowing for more personalized prevention strategies.

Taking Action for Better Heart Health

A low total cholesterol to HDL ratio is indeed beneficial and represents one of the most important modifiable risk factors for cardiovascular disease. By understanding your current ratio and implementing targeted lifestyle changes, you can significantly reduce your risk of heart disease and stroke. Remember that improving your ratio is a gradual process that requires consistency and patience.

Start by getting a comprehensive lipid panel to establish your baseline, then focus on sustainable changes like improving your diet, increasing physical activity, and managing stress. Small, consistent improvements in your ratio can translate to substantial reductions in cardiovascular risk over time. With regular monitoring and commitment to heart-healthy habits, achieving and maintaining an optimal cholesterol ratio is an attainable goal that will benefit your health for years to come.

References

  1. Millán, J., Pintó, X., Muñoz, A., et al. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed][DOI]
  2. Calling, S., Johansson, S. E., Wolff, M., et al. (2021). Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden. BMC Cardiovascular Disorders, 21(1), 163.[PubMed][DOI]
  3. Arsenault, B. J., Rana, J. S., Stroes, E. S., et al. (2009). Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/HDL cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology, 55(1), 35-41.[PubMed][DOI]
  4. Ridker, P. M., Rifai, N., Cook, N. R., et al. (2005). Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA, 294(3), 326-333.[PubMed][DOI]
  5. Fernández-Macías, J. C., Ochoa-Martínez, A. C., Varela-Silva, J. A., & Pérez-Maldonado, I. N. (2019). Atherogenic index of plasma: Novel predictive biomarker for cardiovascular illnesses. Archives of Medical Research, 50(5), 285-294.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my total cholesterol to HDL ratio at home?

You can test your cholesterol ratio at home with SiPhox Health's Heart & Metabolic Program, which includes total cholesterol, HDL cholesterol, and advanced cardiovascular markers. This CLIA-certified program provides lab-quality results with personalized insights delivered to your smartphone.

What is considered a dangerously high cholesterol ratio?

A total cholesterol to HDL ratio above 5:1 is considered high risk, while ratios above 6:1 are dangerously high and require immediate medical attention. These elevated ratios indicate insufficient protective HDL relative to total cholesterol, significantly increasing cardiovascular disease risk.

How quickly can I improve my cholesterol ratio?

With consistent lifestyle changes, you may see improvements in your ratio within 6-12 weeks. Total cholesterol can drop relatively quickly with dietary changes, while HDL increases more gradually. Most people see optimal results after 3-6 months of sustained healthy habits.

Can you have too low of a cholesterol ratio?

While rare, extremely low ratios (below 2.5:1) may occur with very high HDL levels. This is generally not concerning unless total cholesterol is abnormally low (under 120 mg/dL), which could indicate malnutrition, hyperthyroidism, or other health issues requiring medical evaluation.

Does the cholesterol ratio matter if my total cholesterol is normal?

Yes, your ratio remains important even with normal total cholesterol. You could have normal total cholesterol but low HDL, resulting in a poor ratio and increased cardiovascular risk. The ratio provides crucial context that total cholesterol alone cannot reveal.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details